Viloxazine in the Treatment of Attention Deficit Hyperactivity Disorder

Attention deficit hyperactivity disorder (ADHD) is the most common neurodevelopmental disorder in children. Over the past twenty years, research on the disease and its characteristics and treatment options has grown exponentially. The first-line pharmacologic treatment of ADHD is stimulants, which h...

Descripción completa

Detalles Bibliográficos
Autores principales: Edinoff, Amber N., Akuly, Haseeb A., Wagner, John H., Boudreaux, Megan A., Kaplan, Leah A., Yusuf, Shadman, Neuchat, Elisa E., Cornett, Elyse M., Boyer, Andrea G., Kaye, Adam M., Kaye, Alan D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Psychiatry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8718796/
https://www.ncbi.nlm.nih.gov/pubmed/34975586
http://dx.doi.org/10.3389/fpsyt.2021.789982

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8718796/
https://www.ncbi.nlm.nih.gov/pubmed/34975586
http://dx.doi.org/10.3389/fpsyt.2021.789982

Ejemplares similares